Zu-Xiong Huang Selected Research

guanidinopropylsuccinic acid (GPSA)

6/2022

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zu-Xiong Huang Research Topics

Disease

3	Chronic Hepatitis B 06/2022 - 01/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 07/2020
2	Fibrosis (Cirrhosis) 06/2022 - 07/2020
2	Infections 06/2022 - 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2021

Drug/Important Bio-Agent (IBA)

3	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2022 - 07/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2022 - 07/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2022 - 07/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2020
1	guanidinopropylsuccinic acid (GPSA)IBA 06/2022
1	AlbuminsIBA 06/2022
1	Hepatitis B e AntigensIBA 01/2021
1	Ceruloplasmin (Ferroxidase)IBA 07/2020
1	Indicators and Reagents (Reagents)IBA 07/2020
1	Alanine Transaminase (SGPT)IBA 07/2020
1	Telbivudine FDA Link 01/2013
1	NucleosidesIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 07/2020